According to phase 4 trial results, vedolizumab is safer and more effective as a treatment in early Crohn’s disease, compared to late Crohn’s disease.
This open-label, investigator-initiated, phase 4 cohort study enrolled 260 patients with…

According to phase 4 trial results, vedolizumab is safer and more effective as a treatment in early Crohn’s disease, compared to late Crohn’s disease.
This open-label, investigator-initiated, phase 4 cohort study enrolled 260 patients with…

James GallagherHealth and science correspondent
Nye familyScientists have discovered why type 1 diabetes is more severe and aggressive when it develops in young children.
Type…

Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–23.

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan B B, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until it turns completely green. Thank you for your cooperation!

November 12, 2025
…

A health worker prepares to administer a vaccine at a vaccination center in Mexico City, capital of Mexico, Nov. 12, 2025. Mexico City has set up a vaccination center offering influenza, COVID-19, pneumococcal and measles vaccines to the public…

A health worker prepares to administer a vaccine at a vaccination center in Mexico City, capital of Mexico, Nov. 12, 2025. Mexico City has set up a vaccination center offering influenza, COVID-19, pneumococcal and measles vaccines to the public…

A health worker prepares to administer a vaccine at a vaccination center in Mexico City, capital of Mexico, Nov. 12, 2025. Mexico City has set up a vaccination center offering influenza, COVID-19, pneumococcal and measles vaccines to the public…